Plunkett Research Online: Dendreon Corporation

DENDREON CORPORATION (Subsidiary) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Dendreon Corporation, a subsidiary of Sanpower Group Co., Ltd., discovers, develops and commercializes active cellular immunotherapy and small molecule product candidates to treat a wide range of cancers. The company’s FDA-approved product is Provenge (sipuleucel-T), an autologous cellular immunoth.....


DENDREON CORPORATION

Ticker: Subsidiary
Exchange:
Parent Company:
Employees:
Fiscal Year Ends in

Phone: 206 256-4545
Fax: 206 256-0571
Address: 1208 Eastlake Ave. E.
Seattle, WA 98102 United States

Types Of Business
Industry Ranks

Industry NAICS code:
Parent Company: Sanpower Group Co Ltd

ContactsDescription

Jim CaggianoCEO
Andrew SandlerChief Medical Officer/Executive VP
See More
Dendreon Corporation, a subsidiary of Sanpower Group Co., Ltd., discovers, develops and commercializes active cellular immunotherapy and small molecule product candidates to treat a wide range of cancers. The company’s FDA-approved product is Provenge (sipuleucel-T), an autologous cellular immunoth.....See More See More

$USD, In whole numbers 2017201620152014201320122011
Sales
Profits
Brands, Divisions and AffiliatesTop Salaries
Salary
Bonus
Other ThoughtsCorporate Culture